Summary of Study ST000876
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000607. The data can be accessed directly via it's Project DOI: 10.21228/M86Q34 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Study ID | ST000876 |
| Study Title | Human serum for a patient with neuropathy being treated with L-serine. |
| Study Type | drug dosage |
| Study Summary | Oral serine dosing over 52 week study period |
| Institute | University of Helsinki |
| Department | Molecular Neurology |
| Last Name | Ylikallio |
| First Name | Emil |
| Address | Hartmaninkatu 8, 00290 Helsinki, Finland |
| emil.ylikallio@helsinki.fi | |
| Phone | None |
| Submit Date | 2017-09-05 |
| Publications | Clinical and metabolic consequences of L-serine supplementation in hereditary sensory and autonomic neuropathy type 1C, Cold Spring Harbor Molecular Case Studies |
| Analysis Type Detail | MS(Dir. Inf.) |
| Release Date | 2017-10-11 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Combined analysis:
| Analysis ID | AN001413 |
|---|---|
| Chromatography ID | CH000988 |
| MS ID | MS001304 |
| Analysis type | MS |
| Chromatography type | None (Direct infusion) |
| Chromatography system | None |
| Column | none |
| MS Type | ESI |
| MS instrument type | Triple quadrupole |
| MS instrument name | Waters Xevo-TQ-S |
| Ion Mode | POSITIVE |
| Units | µM |
